Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Gross Margin (2020 - 2025)

Agilon Health's Gross Margin history spans 6 years, with the latest figure at 8.02% for Q4 2025.

  • For Q4 2025, Gross Margin fell 37546.0% year-over-year to 8.02%; the TTM value through Dec 2025 reached 44.59%, down 10314.0%, while the annual FY2025 figure was 74.05%, 2582.0% down from the prior year.
  • Gross Margin reached 8.02% in Q4 2025 per AGL's latest filing, up from 3.77% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 625.27% in Q4 2021 to a low of 3.77% in Q3 2025.
  • Average Gross Margin over 5 years is 111.03%, with a median of 77.86% recorded in 2025.
  • Peak YoY movement for Gross Margin: surged 61653bps in 2021, then crashed -37546bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 625.27% in 2021, then crashed by -50bps to 310.95% in 2022, then crashed by -63bps to 113.86% in 2023, then surged by 237bps to 383.47% in 2024, then tumbled by -98bps to 8.02% in 2025.
  • Per Business Quant, the three most recent readings for AGL's Gross Margin are 8.02% (Q4 2025), 3.77% (Q3 2025), and 99.84% (Q2 2025).